Review renews questions about oseltamivir benefits - CIDRAP
ABC NewsReview renews questions about oseltamivir benefitsCIDRAPJan 19, 2012 (CIDRAP News) – A lengthy new analysis of unpublished clinical trial data is renewing questions about the effectiveness of the influenza drug oseltamivir (Tamiflu), saying that although the drug shortens flu symptoms by about a day, .
NanoViricides Inc. Submits Pre-IND Briefing Document for its Anti-Influenza ... - EON: Enhanced Online News (press release)
NanoViricides Inc.
Doctors raise questions over influenza drug - Mediplacements
MediplacementsDoctors raise questions over influenza drugMediplacementsDoctors have raised a number of questions surrounding the safety of the commonly used anti-influenza drug oseltamivir.
Why do generic drugs have such tongue-twisting names? - MARQUES Class 46
MARQUES Class 46Why do generic drugs have such tongue-twisting names?MARQUES Class 46'Oseltamivir.
Avian flu threatens to claim additional life - Jakarta Post
Avian flu threatens to claim additional lifeJakarta PostThe ministry has also distributed anti-influenza drugs called Oseltamivir to health care facilities, including both hospitals and community health centers, free of charge.